These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 20177885)
1. Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus protein. Tripathi NK; Shukla J; Biswal KC; Lakshmana Rao PV Appl Microbiol Biotechnol; 2010 May; 86(6):1795-803. PubMed ID: 20177885 [TBL] [Abstract][Full Text] [Related]
2. Production and characterization of recombinant dengue virus type 4 envelope domain III protein. Tripathi NK; Babu JP; Shrivastva A; Parida M; Jana AM; Rao PV J Biotechnol; 2008 Apr; 134(3-4):278-86. PubMed ID: 18342971 [TBL] [Abstract][Full Text] [Related]
3. Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli. Tripathi NK; Shrivastava A; Biswal KC; Rao PV Biotechnol J; 2011 May; 6(5):604-8. PubMed ID: 21538895 [TBL] [Abstract][Full Text] [Related]
4. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli. Jaiswal S; Khanna N; Swaminathan S Protein Expr Purif; 2004 Jan; 33(1):80-91. PubMed ID: 14680965 [TBL] [Abstract][Full Text] [Related]
5. Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli. Tripathi NK; Shrivastava A; Biswal KC; Rao PV Appl Microbiol Biotechnol; 2012 Sep; 95(5):1179-89. PubMed ID: 22562165 [TBL] [Abstract][Full Text] [Related]
6. Production of recombinant Chikungunya virus envelope 2 protein in Escherichia coli. Tripathi NK; Priya R; Shrivastava A Appl Microbiol Biotechnol; 2014 Mar; 98(6):2461-71. PubMed ID: 24337252 [TBL] [Abstract][Full Text] [Related]
7. Cloning and expression of domain III of the envelope gene of Japanese encephalitis virus: evaluation for early clinical diagnosis by IgM ELISA. Shukla J; Bhargava R; Dash PK; Parida M; Tripathi N; Rao PV J Virol Methods; 2009 Jun; 158(1-2):165-70. PubMed ID: 19428586 [TBL] [Abstract][Full Text] [Related]
8. Production of recombinant nonstructural 1 protein in Escherichia coli for early detection of Japanese encephalitis virus infection. Tripathi NK; Kumar JS; Biswal KC; Rao PV Microb Biotechnol; 2012 Sep; 5(5):599-606. PubMed ID: 22452851 [TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis. Konishi E; Mason PW; Shope RE J Med Virol; 1996 Jan; 48(1):76-9. PubMed ID: 8825714 [TBL] [Abstract][Full Text] [Related]
10. Development of a simple fed-batch process for the high-yield production of recombinant shiga toxin B-chain protein. Sharma K; Gupta P; Kumar Singh A; Gopalan N; Kumar Dhaked R; Lakshmana Rao PV Protein Pept Lett; 2012 Feb; 19(2):228-37. PubMed ID: 21838697 [TBL] [Abstract][Full Text] [Related]
11. Development of the second generation Japanese encephalitis (JE) vaccine. Igarashi A Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):493-500. PubMed ID: 3217827 [TBL] [Abstract][Full Text] [Related]
12. Production of IgM specific recombinant dengue multiepitope protein for early diagnosis of dengue infection. Tripathi NK; Shrivastva A; Pattnaik P; Parida M; Dash PK; Gupta N; Jana AM; Rao PV Biotechnol Prog; 2007; 23(2):488-93. PubMed ID: 17256968 [TBL] [Abstract][Full Text] [Related]
13. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge. Chia SC; Leung PS; Liao CP; Huang JH; Lee ST Microb Pathog; 2001 Jul; 31(1):9-19. PubMed ID: 11427032 [TBL] [Abstract][Full Text] [Related]
14. Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2]. Shin CS; Hong MS; Bae CS; Lee J Biotechnol Prog; 1997; 13(3):249-57. PubMed ID: 9190075 [TBL] [Abstract][Full Text] [Related]
15. Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone. Mutoh E; Ishikawa T; Takamizawa A; Kurata T; Sata T; Kojima A Vaccine; 2004 Jun; 22(20):2599-608. PubMed ID: 15193385 [TBL] [Abstract][Full Text] [Related]
16. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate. Pattnaik P; Babu JP; Verma SK; Tak V; Rao PV J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):184-94. PubMed ID: 17011249 [TBL] [Abstract][Full Text] [Related]
17. [Immunogenicity and antigenicity of Japanese encephalitis virus envelope protein domain III]. Huang Y; Liu S; Yang P; Du Y; Sun Z; Yu W Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1532-7. PubMed ID: 20112698 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of Japanese encephalitis virus envelope protein gene from swine. Fan JM; Luo J; Zhang GP; Chen L; Teng M; Yang MF; Wang L; Wang CQ Lett Appl Microbiol; 2010 Jul; 51(1):11-7. PubMed ID: 20477964 [TBL] [Abstract][Full Text] [Related]
19. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy]. Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615 [TBL] [Abstract][Full Text] [Related]
20. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice. Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]